CONSTRUCTIONS HYBRIDES ET LEUR UTILISATION POUR PRODUIRE DES ANTICORPS PRESENTANT UNE AFFINITE DE LIAISON ACCRUE POUR LE RECEPTEUR FC ET FONCTION D'EFFECTEUR

• 收藏
• 分享

专利权人:

GLYCART BIOTECHNOLOGY AG

发明人:

UMANA, PABLO,BRUENKER, PETER,FERRARA, CLAUDIA,SUTER, TOBIAS

申请号：

CA2513797

公开号：

CA2513797C

申请日:

2004.01.22

申请国别(地区):

CA

年份:

2016

代理人:

摘要：

The present invention relates to the field of glycosylation engineering ofproteins. More particularly, the present invention relates to nucleic acidmolecules, including fusion constructs, having catalytic activity and the useof same in glycosylation engineering of host cells to generate polypeptideswith improved therapeutic properties, including antibodies with increased Fcreceptor binding and increased effector function.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/